Finally, in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study, the AT1R blocking, RAAS inhibitor prevented more cardiovascular morbidity and deaths compared to atenolol, despite similar blood pressure reduction [71]. Here, AGTR1 is linked to hypertensive disorder.